Sinovac | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Thursday
February 02, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
THURSDAY, FEBRUARY 02, 2023

Sinovac

Sinovac to invest Tk5,000cr in plasma-based medicines
Health

Sinovac to invest Tk5,000cr in plasma-based medicines

The Sinovac vaccine is pictured at StarMed Specialist Centre, a private medical centre, in Singapore July 13, 2021. Photo :Reuters
Coronavirus chronicle

Sinovac Covid-19 shot with Pfizer booster less effective against Omicron - study

UK to add China's Sinovac, India's Covaxin to approved vaccine list
Coronavirus chronicle

UK to add China's Sinovac, India's Covaxin to approved vaccine list

One million doses of Sinovac vaccine arrive in Dhaka
Covid-19 in Bangladesh

One million doses of Sinovac vaccine arrive in Dhaka

A health worker holds a syringe and a vial of the Sinovac coronavirus disease (Covid-19) vaccine at a market in Bangkok, Thailand, March 17, 2021. Photo :Reuters
Coronavirus chronicle

Thailand to cease Sinovac vaccine use when stocks end this month

Malaysia approves Sinovac's Covid-19 vaccine for ages 12 to 17
Coronavirus chronicle

Malaysia approves Sinovac's Covid-19 vaccine for ages 12 to 17

Photo: Collected
Bangladesh

Bangladesh approves Sinovac Covid-19 vaccine for emergency use

Photo: Sumit Dayal/Bloomberg
Bangladesh

Bangladesh starts administering Sinopharm vaccine

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
Coronavirus chronicle

EU drug regulator begins real-time review of Sinovac's Covid-19 vaccine

FILE PHOTO: An employee holds a vial containing CoronaVac, Sinovac Biotech's vaccine against the coronavirus disease (COVID-19), at Butantan biomedical production center in Sao Paulo, Brazil January 12, 2021. REUTERS/Amanda Perobelli
Coronavirus chronicle

Sinovac vaccine 80 pct effective against Covid-19-related death: Chilean gov’t study

Dispensed vials of the Sinovac COVID-19 vaccine are seen as the Thai resort island of Phuket rushes to vaccinate its population amid the coronavirus disease (COVID-19) outbreak, and ahead of a July 1 ending of strict quarantine for overseas visitors, to bring back tourism revenue in Phuket, Thailand, April 1, 2021. REUTERS/Jorge Silva
Coronavirus chronicle

China’s Sinovac Covid-19 vaccine 67% effective in preventing symptomatic infection - Chile govt report

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. /Reuters
Coronavirus chronicle

Sinovac vaccine effective in children

A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
Coronavirus chronicle

Ukraine approves China's Sinovac Covid-19 vaccine

  • Show More
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]